GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Voyageur Pharmaceuticals Ltd (TSXV:VM) » Definitions » Scaled Net Operating Assets

Voyageur Pharmaceuticals (TSXV:VM) Scaled Net Operating Assets : 0.63 (As of Feb. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Voyageur Pharmaceuticals Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Voyageur Pharmaceuticals's operating assets for the quarter that ended in Feb. 2024 was C$2.31 Mil. Voyageur Pharmaceuticals's operating liabilities for the quarter that ended in Feb. 2024 was C$0.95 Mil. Voyageur Pharmaceuticals's Total Assets for the quarter that ended in Nov. 2023 was C$2.16 Mil. Therefore, Voyageur Pharmaceuticals's scaled net operating assets (SNOA) for the quarter that ended in Feb. 2024 was 0.63.


Voyageur Pharmaceuticals Scaled Net Operating Assets Historical Data

The historical data trend for Voyageur Pharmaceuticals's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Voyageur Pharmaceuticals Scaled Net Operating Assets Chart

Voyageur Pharmaceuticals Annual Data
Trend Dec14 Dec15 Nov16 Nov17 Nov18 Nov19 Nov20 Nov21 Nov22 Nov23
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.65 0.36 0.89 0.57 0.70

Voyageur Pharmaceuticals Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.77 0.62 0.77 0.68 0.63

Competitive Comparison of Voyageur Pharmaceuticals's Scaled Net Operating Assets

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Voyageur Pharmaceuticals's Scaled Net Operating Assets Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's Scaled Net Operating Assets falls into.



Voyageur Pharmaceuticals Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Voyageur Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Nov. 2023 is calculated as

Scaled Net Operating Assets (SNOA)(A: Nov. 2023 )
=(Operating Assets (A: Nov. 2023 )-Operating Liabilities (A: Nov. 2023 ))/Total Assets (A: Nov. 2022 )
=(2.162-0.688)/2.095
=0.70

where

Operating Assets(A: Nov. 2023 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.164 - 0.002
=2.162

Operating Liabilities(A: Nov. 2023 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.728 - 0.04 - 0
=0.688

Voyageur Pharmaceuticals's Scaled Net Operating Assets (SNOA) for the quarter that ended in Feb. 2024 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Feb. 2024 )
=(Operating Assets (Q: Feb. 2024 )-Operating Liabilities (Q: Feb. 2024 ))/Total Assets (Q: Nov. 2023 )
=(2.312-0.945)/2.164
=0.63

where

Operating Assets(Q: Feb. 2024 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=2.562 - 0.25
=2.312

Operating Liabilities(Q: Feb. 2024 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=0.985 - 0.04 - 0
=0.945

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Voyageur Pharmaceuticals Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Voyageur Pharmaceuticals (TSXV:VM) Business Description

Traded in Other Exchanges
Address
333 Southwest 7th Avenue, Suite 800, Calgary, AB, CAN, T2P 2Z1
Voyageur Pharmaceuticals Ltd is engaged in the development of pharmaceutical ingredients (API) minerals. The company focuses on developing barium and iodine radiocontrast products and bromine-based pharmaceutical products. It provides its products for medical applications and diagnostics.
Executives
Charles Littlejohn 10% Security Holder

Voyageur Pharmaceuticals (TSXV:VM) Headlines

No Headlines